
CDP Venture Capital Sgr, the largest venture capital investor in Italy and among the largest in Europe, has signed an investment agreement in a capital increase for up to a total of €5 million in NOB 4.0 Srl Società Benefit that owns the digital app and platform Imatra, as part of a larger round of capital increase investment for a total of €8 million, also involving other private investors.
Imatra is a digital fintech and sportstech startup, which aims to build loyalty among the international community of cyclists and cycling enthusiasts around the world, increasing their connection and offering added value to the sport. In fact, through their passion for cycling – in the future replicable for many other sports – Imatra users can generate with their physical activity Imatra Coins, a completely green proprietary digital currency, to be used later on the imatra.com marketplace, where the most important premium branded products of cycling and sports lifestyle are featured.
Two years ago, Fintech Partners, an investment vehicle of SRI Group Global specialising in venture capital, joined the founding team of Manolo Bianchini and Luca Celli. Fintech Partners is led by its main shareholders, Giulio Gallazzi and Bernardo Vacchi. The startup, after its first 18 months of operations, is already projected to reach break-even by the end of 2024, with a positive cash flow.
Imatra aims to generate over €21 million in revenue by the end of its five-year plan (2028), with an expected EBITDA of €9.5 million.
As part of the transaction NOB-Imatra, the company was advised by SRI Group Global, an international group active in Financial Advisory and Corporate Investment Banking, with a team formed by Partner Alessandro Lamura and Senior Advisor Ludovico Corbetta, as well as by Studio Villa e Associati in Bologna for legal aspects and Studio Mascherpa e Associati for tax and financial aspects. CDP Venture Capital was assisted by Spada Partners as financial and tax advisor, and by Curtis, Mallet-Prevost, Colt & Mosle LLP for legal aspects.